BOI Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; Sedative PC Granules to treat anxiety and emotional, and minor sleep disorders; Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; Homéovox for vocal disorders; Homéoplasmine for treating irritated skin and redness; Varésol to treat symptoms of chickenpox; and Arnicare Arthritis for use in the treatment of benign trauma pain. In addition, it offers Dermoplasmine, a plant based multi-use balm that repairs and protects irritated and damaged skin; COVID self-tests and rapid antigenic tests; LABIAMEO, that used to treat outbreaks of localized cold sores; and CONVAMEO to treat physical and mental asthenia. Further, the company provides Quietude, Rhinallergy, Ribes Nigrum Macerate Glycerin 1 DH Boiron, Sabal serrulata Mother Tincture Boiron, Sevameo, Sinupyl, Sportenine, Stodaline Sugar-Free, Stodal Granules, Stodal Syrup, Storinyl, Sedative PC Sublingual Tablet, Tilia Tomentosa Glycerinated Macerate 1DH Boiron, Varesol, Verrulia, Avenoc Suppository, Calendula Cream, Zelaceo, and Zenalia. It offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is based in Messimy, France.…
Industry Peers
Drug Manufacturers - Specialty & GenericKey Statistics
About Boiron (EPA: BOI)
›
Boiron (EPA: BOI) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 2,623 employees.
The shares were at 19.10 EUR on 19 November 2026, down 28.2% over 52 weeks. Its 52-week range is 16.90 EUR to 32.25 EUR: the price is 40.8% below the high and 13.0% above the low.
At a market capitalisation of 331.62M EUR, it trades at 12.6 times trailing earnings and 9.0 times forward earnings. The median trailing P/E of its 17 largest Drug Manufacturers - Specialty & Generic peers is 24.7, a discount of 49% for BOI. It pays a dividend yielding 7.01% (it pays out 89% of its earnings), against a median of 1.90% among the dividend payers in that peer group.
Boiron reports return on equity of 8.3%, an operating margin of 7.9% and revenue down 2.2% year over year.
It holds more cash than debt, a net cash position of 26.87M EUR. Its Piotroski F-score is 5 out of 9, an average reading of its financial health.